normal human plasma (Precision Biologic Inc)
90
Structured Review
Precision Biologic Inc
normal human plasma
Normal Human Plasma, supplied by Precision Biologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+human+reference+plasma/normal+human+plasma/pmc07757006-45-0-4
Average 90 stars, based on 1 article reviews
Normal Human Plasma, supplied by Precision Biologic Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/normal+human+reference+plasma/normal+human+plasma/pmc07757006-45-0-4
Average 90 stars, based on 1 article reviews
normal human plasma - by Bioz Stars,
2026-09
90/100 stars
Images
1) Product Images from "The evolution of factor XI and the kallikrein-kinin system"
Article Title: The evolution of factor XI and the kallikrein-kinin system
Journal: Blood Advances
doi: 10.1182/bloodadvances.2020002456
Figure Legend Snippet: Analysis of cetacean plasma. (A) Activated partial thromboplastin time studies. White bars show average aPTTs of pooled normal human plasma and plasma from a cetacean (a false killer whale). Gray bars show average aPTTs for plasmas from human patients lacking FXII (−XII), FXI (−XI), PK (−PK), or HK (−HK). Black bars indicate average aPTTs for mixtures of equal volumes of human factor-deficient plasmas and false killer whale plasma. Note the normal clotting times for mixtures with human plasma lacking FXI and HK. Bars represent averages of 3 runs for each plasma. (B) Plasma western blots. One-microliter samples of plasma from a false killer whale (F), a human (H), and a mouse (M) were size fractionated by SDS-PAGE and transferred to nitrocellulose. Protein controls (C) for human FXII (XII), FXI (XI), PK, or HK were included. Blots were developed with polyclonal IgGs to each human protein (left column) or monoclonal antibodies raised against mouse FXII (1D7 and 15D10, center column) or mouse FXI (14E11 and 15B4, right column). Note the absence of signals for FXII or PK, and the presence of FXI and HK, in plasma from the false killer whale.
Techniques Used: Clinical Proteomics, Coagulation, Western Blot, SDS Page, Bioprocessing
Related Articles
Clinical Proteomics:Article Title: The evolution of factor XI and the kallikrein-kinin system Article Snippet: Normal human plasma (Precision Biologics); human plasmas lacking PK, FXII, HK, or FXI (George King Biomed); and plasma from a false killer whale (Vancouver Aquarium) were anticoagulated with sodium citrate. .. Article Title: Non-criteria antiphospholipid antibodies and pediatric rheumatic disease: a case series. Article Snippet: PTT testing and dRVVT reagents were manufactured by Stago (Parsippany, NJ). .. Article Title: Discordant Partial Thromboplastin Time (PTT) vs Anti-Xa Heparin Activity. Article Snippet: Owren-Koller buffer was obtained from Diagnostica Stago. .. Pooled normal Article Title: Diagnosis and management of factor XI alloinhibitors in patients with congenital factor XI deficiency-A large single-centre experience. Article Snippet: Correspondence Kirollos Salah Kamel, Katharine Dormandy Haemophilia Centre, Royal Free Hospital NHS Trust, Pond Street, London, NW3 2QG, UK.. Email: Kirollos.Kamel@nhs.net Abstract Introduction: Factor (F) XI deficiency is an inherited bleeding disorder with increased prevalence in Ashkenazi Jews where it is mainly caused by two variants, p.Glu135* (type II, leading to a null allele) and p.Phe301Leu (type III, missense variant).. Inhibitor development is rare, and only seen in severe FXI deficiency (<20 IU/dL) upon exposure to plasma-based products. Article Title: Genetics and Hemostatic Potential in Persons with Mild to Moderate Hemophilia A with a Discrepancy between One-Stage and Chromogenic FVIII Assays. Article Snippet: 1Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden 2Clinical Chemistry, Karolinska University Laboratory, Karolinska University Hospital, Stockholm, Sweden 3Hemostasis Department and Hemophilia Center, Blood Transfusion Institute of Serbia, Belgrade, Serbia 4Coagulation Unit, Department of Hematology, Karolinska University Hospital, Stockholm, Sweden 5Department of Medicine Solna, Karolinska Institutet, Stockholm, Sweden Article Title: Coagulation assay discrepancies in Japanese patients with non-severe hemophilia A. Article Snippet: Patients with non-severe hemophilia A often show discrepancies in factor VIII (FVIII) activity.. However, information on variant-specific coagulation assay characteristics in Japanese patients is limited.. Pathogenic variants were classified into three groups, thrombin-cleavage site (TC), A1-A2-A3 interface (IF), and non-discrepant, with reference to previous studies. Article Title: Towards Biohybrid Lung Development—Fibronectin-Coating Bestows Hemocompatibility of Gas Exchange Hollow Fiber Membranes by Improving Flow-Resistant Endothelialization Article Snippet: .. In parallel, AH or FN coated, but non-endothelialized HFM samples were immersed in normal other:Article Title: The evolution of factor XI and the kallikrein-kinin system Article Snippet: Human FXII, FXIIa, PK, HK, and FIX were from Enzyme Research Laboratories and FXI and α-thrombin were from Haematologic Industries. Positive Control:Article Title: Towards Biohybrid Lung Development—Fibronectin-Coating Bestows Hemocompatibility of Gas Exchange Hollow Fiber Membranes by Improving Flow-Resistant Endothelialization Article Snippet: .. In parallel, AH or FN coated, but non-endothelialized HFM samples were immersed in normal |